CE Marking vs FDA Clearance: What Each Means for Medical Devices

“We already have a CE mark. Can we send the device to our US distributor?”

It is a reasonable question. Your team has spent months preparing evidence, reviewing the device file, and getting the product ready to sell. Starting another regulatory process can feel like doing the same work twice.

But CE marking and FDA clearance answer different questions. CE marking indicates that the manufacturer has completed the applicable European conformity assessment. FDA 510(k) clearance means the FDA has determined that a device is substantially equivalent to a legally marketed device known as a predicate. Neither status automatically opens the other market.

That distinction affects your launch date, budget, documentation, and even the claims your sales team can make. Here is the comparison first, followed by what it means for a real market entry plan.

CE Marking vs FDA Clearance: The Differences at a Glance

The key point: Both statuses relate to a specific device and its intended use. Do not assume that a decision covering one model, version, or set of claims automatically covers another.

Your Device Is CE Marked. What Has Actually Been Established?

For an EU medical device, CE marking follows the applicable conformity assessment. The manufacturer is responsible for demonstrating conformity, preparing the required technical documentation, and meeting the requirements that apply to the device.

A common point of confusion is who assesses that work. Some Class I medical devices can be CE marked without notified body involvement. Other Class I devices, including certain sterile or measuring devices, require a notified body for specified aspects of the assessment. Higher-risk classes generally require notified body involvement.

For a buyer or distributor, “Does it have a CE mark?” is therefore only the first question. The useful follow-up is: Does the declaration of conformity, and any applicable certificate, cover the exact device and intended purpose being offered?

Now imagine that the distributor is based in the US. The CE documentation may contain valuable evidence, but the mark itself does not answer the FDA’s next question.

What Does the FDA Want to Know for a 510(k)?

For a device that requires a 510(k), the manufacturer identifies a suitable legally marketed predicate device and demonstrates substantial equivalence. The FDA reviews the submission and issues a determination. A successful determination is generally what people mean when they say a device is FDA-cleared.

Before searching for a predicate, confirm the device’s US classification. Some devices are exempt from 510(k). A novel device without a suitable predicate may be eligible for the De Novo pathway, while certain devices require premarket approval (PMA). The pathway changes the evidence needed, the submission fee, and the project plan.

FDA-Cleared, FDA-Approved, and FDA-Registered Are Different

If your website calls a 510(k)-cleared device “FDA-approved,” correct the wording. Buyers and distributors need to understand the product’s actual regulatory status.

Can You Reuse a CE File for an FDA 510(k)?

You may be able to reuse evidence. You cannot convert a CE mark into FDA clearance.

Suppose your CE file already contains device specifications, performance test reports, and information supporting the intended purpose. Those materials provide a starting point for a US gap review. Your team still needs to confirm the FDA classification, proposed US claims, whether a 510(k) is required, and whether the evidence supports comparison with a suitable predicate.

The same principle applies in reverse. A manufacturer entering the EU after obtaining FDA clearance can review its existing evidence for reuse, but must still complete the applicable EU conformity assessment.

Where OMC Medical can help: A market entry gap review compares your existing tests, technical documents, and claims with the requirements for each target market. It shows what can support the next submission, what needs updating, and what work has yet to begin.

How Much Does CE Marking vs FDA Clearance Cost?

The first budgeting mistake is comparing one FDA submission fee with a quote labelled “CE certification.” Neither figure necessarily represents the full cost of getting a device ready for sale.

For the US, the FDA publishes user fees. For EU CE marking, there is no single EU-wide price: notified bodies publish standard fees, and the work required depends on the device. In either market, testing, documentation, clinical evidence, quality system work, and ongoing obligations can add to the total.

Published FDA Medical Device Fees for FY 2026 and FY 2027

If your submission reaches the FDA just before or after 1 October 2026, the applicable fiscal year matters. These are FDA fees, not complete project prices.

The small business submission fee requires FDA qualification; it is not an automatic discount. The annual establishment registration fee is separate from the 510(k) fee. Confirm the applicable fee when preparing to submit, because FDA bases the submission fee on when it receives the application.

What Should Go Into a CE Marking Quote?

Ask for costs to be separated so you can see what the quote actually covers:

EU notified bodies must make lists of their standard conformity assessment fees publicly available. Those lists help with initial research, but a quote based on your device and assessment scope is more useful for budgeting.

A better question than “Which route is cheaper?” is: “What evidence do we already have, and what will we still need to create for each market?”

What If Your Launch Plan Also Includes the UK or India?

A two-column CE-versus-FDA comparison cannot answer every market access question. The UK and India each need a separate review.

Great Britain and Northern Ireland

For Great Britain—England, Scotland, and Wales—eligible CE-marked medical devices remain accepted under transitional arrangements. Depending on the device and the EU legislation it meets, the current end date is 30 June 2028 or 30 June 2030. Great Britain also has a UKCA route and applicable MHRA registration requirements.

Northern Ireland follows its applicable EU medical device framework. If a company says it is “launching in the UK,” the regulatory team should confirm whether that means Great Britain, Northern Ireland, or both.

For budgeting, the MHRA fee structure introduced on 1 April 2026 includes an annual £300 fee per applicable Level 2 GMDN category, or Level 1 where no Level 2 exists. Registrations made during the charging period are charged on a pro rata basis. This is a registration charge, not the total cost of UK market entry.

India

Neither CE marking nor FDA clearance automatically permits import or sale in India. The manufacturer and Indian applicant must check the applicable CDSCO route, classification, supporting documents, and licence requirements for the specific device. Overseas regulatory evidence may help support an application, but it does not replace the Indian process.

Which Route Should You Pursue First?

Start with the first shipment your company actually wants to make, then work backwards:

1. Name the destination. The EU, US, Great Britain, Northern Ireland, and India need separate market checks.
2. Fix the intended purpose and claims. These shape the assessment in each market.
3. Classify the device for each destination. Do not carry one market’s classification into another.
4. Map your existing evidence. Identify useful reports and the gaps each route leaves.
5. Budget for the full launch. Include submission or assessment fees, preparation work, and ongoing obligations.

For a manufacturer targeting both the EU and US, this can become one coordinated work plan with two distinct regulatory outcomes. The team can make appropriate use of existing evidence while keeping each market’s requirements clear.

Frequently Asked Questions

Is CE marking the same as FDA clearance?

No. CE marking follows the applicable European conformity assessment. FDA 510(k) clearance is the FDA’s determination that the submitted device is substantially equivalent to a legally marketed predicate.

Is CE marking cheaper than FDA clearance?

There is no universal answer. The FDA publishes a 510(k) submission fee, while there is no single EU-wide notified body assessment price. Testing, clinical evidence, documentation, and other device-specific work can substantially change the total in either market.

Can the same medical device be CE marked and FDA cleared?

Yes. The manufacturer must meet the requirements applicable to that device in both markets. Holding one status does not automatically provide the other.

Does FDA clearance mean FDA approval?

No. A successful 510(k) results in clearance. PMA is an approval pathway, while De Novo is a separate route for eligible novel device types.

Does a CE mark allow medical device sales in the UK?

Eligible CE-marked devices may be placed on the Great Britain market under current transitional rules, subject to the applicable deadline and other requirements. Northern Ireland follows a different framework. Check the current rules for the exact device and destination.

Make the Next Market a Planned Launch

If you already have a CE mark or FDA clearance, your team has done meaningful work. The next step is to find out which parts of that work answer the next market’s questions. That gives you a launch schedule and budget based on your actual device rather than a generic certification estimate.

Planning an EU, US, UK, or India launch? Speak with OMC Medical about your device, intended purpose, current regulatory status, and target countries. Our team can help review the applicable pathways and documentation gaps before you commit to assessment fees or a distributor launch date.